Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Leukemia · 2018 · PMC6035153 · PMID 29472724

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

a nonsignificant trendp = 0.11not close (p > 0.1)

Among 46 patients with NPM1 mutation, there was a nonsignificant trend towards higher molecular MRD levels in patients with ( n = 22) compared to those without persisting pre-leukemic mutations ( n = 24; p = 0.11; Fig. 4a ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.